lobbying_activities: 2778059

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2778059	cdde247e-a5e2-4d1b-ada5-d875a321db65	Q1	TIBER CREEK GROUP	20744	JAZZ PHARMACEUTICALS	2022	first_quarter	MED	Issues related to the FDA and S. 3032 - the FDA STATES Act (115th Congress), and Health and Human Services pertaining to CBD policies.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2022-04-18T10:42:43-04:00